Ohcanbohtosat - Yu. M. Gomon
- Čájehuvvo 1 - 11 / 11
-
1
Efficacy of alectinib in comparison with lorlatinib in patients with ALK-positive non-small cell lung cancer: pharmacoeconomic study Dahkki A. S. Kolbin, Yu. M. Gomon, M. A. Proskurin, Yu. E. Balykina
Almmustuhtton 2023Hildobáiki: Láddejuvvo…Connect to this object online.
Sajádat: Láddejuvvo…
Girji -
2
Factors associated with adverse outcome among hospitalized patients with moderate to severe COVID-19 Dahkki S. A. Mishinova, Yu. M. Gomon, A. S. Kolbin, E. V. Verbitskaya, T. I. Galimov
Almmustuhtton 2023Hildobáiki: Láddejuvvo…Connect to this object online.
Sajádat: Láddejuvvo…
Girji -
3
A systematic review of real-world clinical practice data in COVID-19: non-interventional studies Dahkki S. A. Mishinova, Yu. M. Gomon, A. S. Kolbin, V. V. Strizheletsky, I. G. Ivanov
Almmustuhtton 2022Hildobáiki: Láddejuvvo…Connect to this object online.
Sajádat: Láddejuvvo…
Girji -
4
Socio-economic burden of COVID-19 in the Russian Federation Dahkki A. S. Kolbin, D. Yu. Belousov, Yu. M. Gomon, Yu. E. Balykina, I. G. Ivanov
Almmustuhtton 2020Hildobáiki: Láddejuvvo…Connect to this object online.
Sajádat: Láddejuvvo…
Girji -
5
The real practice of clinical and economic research of drugs included in the Federal Program of High-Cost Nosologies Dahkki A. S. Kolbin, Yu. M. Gomon, A. R. Kasimova, A. A. Kurylev, A. E. Bem
Almmustuhtton 2022Hildobáiki: Láddejuvvo…Connect to this object online.
Sajádat: Láddejuvvo…
Girji -
6
Cystic fibrosis as a social-economic burden Dahkki A. S. Kolbin, Yu. M. Gomon, O. I. Karpov, Yu. E. Balykina, M. A. Proskurin
Almmustuhtton 2021Hildobáiki: Láddejuvvo…Connect to this object online.
Sajádat: Láddejuvvo…
Girji -
7
Approaches to Assessing the Safety of Medicines during the COVID-19 Pandemic Using the Example of Azithromycin Dahkki Yu. M. Gomon, A. R. Kasimova, A. S. Kolbin, V. V. Strizheletsky, I. G. Ivanov, S. O. Mazurenko
Almmustuhtton 2022Hildobáiki: Láddejuvvo…Connect to this object online.
Sajádat: Láddejuvvo…
Girji -
8
Socioeconomic and global burden of COVID-19 Dahkki A. S. Kolbin, Yu. M. Gomon, Yu. E. Balykina, D. Yu. Belousov, V. V. Strizheletskiy, I. G. Ivanov
Almmustuhtton 2021Hildobáiki: Láddejuvvo…Connect to this object online.
Sajádat: Láddejuvvo…
Girji -
9
ECONOMIC ASSESSMENT OF THE EFFECTIVENESS AND SAFETY OF THE COMMONLY PRACTICED PERIOPERATIVE ANTIBIOTIC PROPHYLAXIS (BASED ON AN EARLIER EPIDEMIOLOGICAL SURVEY OF MULTIDISCIPLINARY... Dahkki Yu. M. Gomon, A. S. Kolbin, S. V. Sidorenko, A. M. Kuzhel', A. V. Repina, Yu. V. Lobzin, Yu. E. Balykina
Almmustuhtton 2017Hildobáiki: Láddejuvvo…Connect to this object online.
Sajádat: Láddejuvvo…
Girji -
10
Modeling microbial drug-resistance: from mathematics to pharmacoeconomics Dahkki Yu. M. Gomon, M. A. Arepyeva, Yu. E. Balykina, A. S. Kolbin, A. A. Kurylev, M. A. Proskurin, S. V. Sidorenko
Almmustuhtton 2018Hildobáiki: Láddejuvvo…Connect to this object online.
Sajádat: Láddejuvvo…
Girji -
11
Efficiency of Levilimab in patients with moderate and severe COVID-19 Dahkki Yu. M. Gomon, V. V. Strizheletsky, I. G. Ivanov, Yu. E. Balykina, M. V. Ermolyev, A. S. Kolbin, M. V. Livshits, T. A. Usmanova, A. M. Fakhrutdinova, Yu. S. Konstantinova, A. P. Gubanov
Almmustuhtton 2023Hildobáiki: Láddejuvvo…Connect to this object online.
Sajádat: Láddejuvvo…
Girji